Philip Kim & Disc Medicine
3 shared events · Importance 3 · Last updated May 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Philip Kim: Philip Kim>>> is an attorney at Rosen Law Firm>>> and a contact person for investors interested in joining the class action.
Disc Medicine: Disc Medicine received a Complete Response Letter from the United States — Food and Drug Administration for its bitopertin program, leading to a significant drop in its stock price and a securities investigation.
Apr 29, 2026 · 20 articles
Regulatory
Disc Medicine: Disc Medicine, Inc. received a Complete Response Letter from the United States — Food and Drug Administration regarding its bitopertin program, leading to a 22% stock price drop and subsequent securities claims investigation.
May 01, 2026 · 6 articles
NEWSDESK
Explore this relationship live
Track how Philip Kim and Disc Medicine interact across events, view sentiment trends, and discover connected entities.
Open Dashboard